Latest Racing News

Page 5 of 34
Racura Oncology reported a $4.1 million loss for H1 FY26, reflecting heavy investment in clinical trials and intellectual property. The company also boosted cash reserves through capital raises and rebranded from Race Oncology.
Ada Torres
Ada Torres
27 Feb 2026
Ainsworth Game Technology reported a 10% revenue increase to AUD 290.8 million for 2025 but posted a net loss of AUD 19.2 million, driven by a significant goodwill impairment and foreign currency headwinds. The company’s strategic investments and market challenges set the stage for a pivotal year ahead.
Victor Sage
Victor Sage
27 Feb 2026
Virgin Australia has reported robust first-half FY26 results, with underlying EBIT up 11.7% driven by strong leisure travel and transformation gains, despite inflationary pressures.
Victor Sage
Victor Sage
27 Feb 2026
BetMakers Technology Group Ltd reported an 11.4% rise in half-year revenue to $46.1 million alongside a dramatic 80% reduction in losses, setting the stage for accelerated global growth and a strategic US market push.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Delorean Corporation reports a significant half-year loss as it pivots from contractor to bioenergy infrastructure owner, advancing key projects but facing financial covenant breaches.
Maxwell Dee
Maxwell Dee
26 Feb 2026
PointsBet Holdings Limited reports a 4% revenue increase in H1 FY26 following MIXI’s acquisition of a controlling stake, with contrasting performances in Australia and Canada shaping the group’s outlook.
Victor Sage
Victor Sage
26 Feb 2026
Firebird Metals has locked in exclusive global rights to five critical LMFP patents, solidifying its position in the lithium-ion battery materials market and paving the way for its Australian Demonstration Plant.
Maxwell Dee
Maxwell Dee
26 Feb 2026
Tungsten Mining is pursuing a US stock exchange listing to tap into deeper capital markets and strengthen ties with US government and industry stakeholders, complementing its existing ASX listing.
Maxwell Dee
Maxwell Dee
26 Feb 2026
Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.
Ada Torres
Ada Torres
25 Feb 2026
Tabcorp Holdings reported a modest 1% revenue increase for the half year ending December 2025, while adjusted net profit after tax jumped 61.5%, prompting a 50% rise in the interim dividend.
Victor Sage
Victor Sage
25 Feb 2026
Synertec Corporation has won operational technology contracts exceeding $1 million with Sydney Water, marking a significant step in its national expansion within Australia's water infrastructure sector.
Nora Hopper
Nora Hopper
20 Feb 2026
Viking Mines has completed due diligence on its Nevada tungsten portfolio, confirming high-grade mineralisation and fast-tracking acquisition and exploration to meet urgent US supply needs.
Maxwell Dee
Maxwell Dee
20 Feb 2026

Browse the archive

Full archive